Salt Lake City, UT – According to filings with the U.S. Securities and Exchange Commission, Carterra is raising $6,999,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Josh Eckman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Carterra

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA instrument for monoclonal antibody (mAb) screening and characterization combines patented microfluidics technology with real-time High Throughput Surface Plasmon Resonance (HT-SPR) and industry leading Kinetic and Epitope analysis and visualization software, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms.

To learn more about Carterra, visit http://carterra-bio.com/

Contact:
Josh Eckman, Chief Executive Officer
844-642-7635
jeckman@carterra-bio.com
https://www.linkedin.com/in/josh-eckman-328b07/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved